Delatestryl
Please select a testosterone article from the list below:
- Business Wire - Alkermes and Indevus Announce Positive Results from Phase 2a Clinical Study of ALKS 27 for the Treatment of COPD
- M2 Presswire - Morning Alert for Indevus Pharmaceuticals Inc.
- M2 Presswire - Current Research on Indevus Pharmaceuticals Inc.
- Business Wire - Alkermes and Indevus Announce Initiation of Phase 2a Clinical Study of ALKS 27 for the Treatment of COPD
- M2 Presswire - Indevus Pharmaceuticals Inc is Added to the Bellwether Watch list.
- M2 Presswire - Analysis of Indevus Pharmaceuticals Inc.
- Business Wire - Alkermes and Indevus Announce Joint Collaboration to Develop Inhaled Formulation of Trospium Chloride for the Treatment of COPD
- M2 Presswire - Fundamental Review for Indevus Pharmaceuticals Inc.
- BIOTECH Patent News - Indevus to acquire Valera.
- Business Wire - Savient Pharmaceuticals Reports Third Quarter Financial Results
Wednesday 26th of September 2007
Business Wire - Alkermes and Indevus Announce Positive Results from Phase 2a Clinical Study of ALKS 27 for the Treatment of COPD
Wednesday 26th of September 2007, 12:00 amSeptember 26, 2007 -- - ALKS 27 Showed a Sustained Improvement in Lung Function Over 24 Hours - CAMBRIDGE & LEXINGTON, Mass. -- Alkermes, Inc. (NASDAQ: ALKS) and...
Wednesday 27th of June 2007
M2 Presswire - Morning Alert for Indevus Pharmaceuticals Inc.
Wednesday 27th of June 2007, 12:00 amJune 27, 2007 -- M2 PRESSWIRE-27 June 2007-Biotech News: Morning Alert for Indevus Pharmaceuticals Inc(C)1994-2007 M2 COMMUNICATIONS LTD RDATE:27062007 Morning...
Thursday 7th of June 2007
M2 Presswire - Current Research on Indevus Pharmaceuticals Inc.
Thursday 7th of June 2007, 12:00 amJune 7, 2007 -- M2 PRESSWIRE-7 June 2007-Biotech News: Current Research on Indevus Pharmaceuticals Inc(C)1994-2007 M2 COMMUNICATIONS LTD RDATE:07062007...
Wednesday 25th of April 2007
Business Wire - Alkermes and Indevus Announce Initiation of Phase 2a Clinical Study of ALKS 27 for the Treatment of COPD
Wednesday 25th of April 2007, 12:00 amApril 25, 2007 -- CAMBRIDGE & LEXINGTON, Mass. -- Alkermes, Inc. (Nasdaq: ALKS) and Indevus Pharmaceuticals, Inc. (Nasdaq: IDEV) today announced the initiation of...
Sunday 25th of March 2007
M2 Presswire - Indevus Pharmaceuticals Inc is Added to the Bellwether Watch list.
Sunday 25th of March 2007, 11:00 pmMarch 26, 2007 -- M2 PRESSWIRE-26 March 2007-Biotech News: Indevus Pharmaceuticals Inc is Added to the Bellwether Watch list(C)1994-2007 M2 COMMUNICATIONS LTD...
Friday 2nd of March 2007
M2 Presswire - Analysis of Indevus Pharmaceuticals Inc.
Friday 2nd of March 2007, 12:00 amMarch 2, 2007 -- M2 PRESSWIRE-2 March 2007-Biotech News: Analysis of Indevus Pharmaceuticals Inc(C)1994-2007 M2 COMMUNICATIONS LTD RDATE:02032007 Analysis of...
Thursday 4th of January 2007
Business Wire - Alkermes and Indevus Announce Joint Collaboration to Develop Inhaled Formulation of Trospium Chloride for the Treatment of COPD
Thursday 4th of January 2007, 12:00 amJanuary 4, 2007 -- -- Companies Report Phase 1 Study Results -- CAMBRIDGE, Mass. & LEXINGTON, Mass. -- Alkermes, Inc. (Nasdaq: ALKS) and Indevus Pharmaceuticals,...
Tuesday 12th of December 2006
M2 Presswire - Fundamental Review for Indevus Pharmaceuticals Inc.
Tuesday 12th of December 2006, 12:00 amDecember 12, 2006 -- M2 PRESSWIRE-12 December 2006-Biotech News: Fundamental Review for Indevus Pharmaceuticals Inc(C)1994-2006 M2 COMMUNICATIONS LTD RDATE:12122006...
Friday 1st of December 2006
BIOTECH Patent News - Indevus to acquire Valera.
Friday 1st of December 2006, 12:00 amDecember 1, 2006 -- Indevus Pharmaceuticals, Inc. (Lexington, MA) and Valera Pharmaceuticals, Inc. (Cranbury, NJ) have entered into a definitive agreement under which...
Monday 30th of October 2006
Business Wire - Savient Pharmaceuticals Reports Third Quarter Financial Results
Monday 30th of October 2006, 12:00 amOctober 30, 2006 -- Operating Profits from Continuing Operations of $1.6 Million for the Quarter EAST BRUNSWICK, N.J. -- Savient Pharmaceuticals, Inc. (NASDAQ: SVNT)...